NOVARTIS | KEMP & CO | NOVARTIS/ KEMP & CO |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.7 | 199.4 | 13.4% | View Chart |
P/BV | x | 3.3 | 0.4 | 802.0% | View Chart |
Dividend Yield | % | 4.6 | 1.3 | 356.7% |
NOVARTIS KEMP & CO |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
KEMP & CO Mar-23 |
NOVARTIS/ KEMP & CO |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 893 | 85.5% | |
Low | Rs | 554 | 485 | 114.2% | |
Sales per share (Unadj.) | Rs | 153.4 | 27.6 | 555.6% | |
Earnings per share (Unadj.) | Rs | 41.9 | 10.9 | 385.1% | |
Cash flow per share (Unadj.) | Rs | 44.3 | 13.0 | 339.9% | |
Dividends per share (Unadj.) | Rs | 47.50 | 12.00 | 395.8% | |
Avg Dividend yield | % | 7.2 | 1.7 | 414.0% | |
Book value per share (Unadj.) | Rs | 314.2 | 2,270.8 | 13.8% | |
Shares outstanding (eoy) | m | 24.69 | 1.08 | 2,286.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 25.0 | 17.2% | |
Avg P/E ratio | x | 15.7 | 63.4 | 24.8% | |
P/CF ratio (eoy) | x | 14.9 | 52.8 | 28.1% | |
Price / Book Value ratio | x | 2.1 | 0.3 | 691.0% | |
Dividend payout | % | 113.5 | 110.4 | 102.8% | |
Avg Mkt Cap | Rs m | 16,262 | 744 | 2,185.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 13 | 2,750.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 30 | 12,700.9% | |
Other income | Rs m | 581 | 27 | 2,182.9% | |
Total revenues | Rs m | 4,369 | 56 | 7,740.1% | |
Gross profit | Rs m | 651 | -11 | -5,759.3% | |
Depreciation | Rs m | 61 | 2 | 2,578.7% | |
Interest | Rs m | 18 | 0 | - | |
Profit before tax | Rs m | 1,154 | 13 | 8,889.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 1 | 9,693.5% | |
Profit after tax | Rs m | 1,034 | 12 | 8,804.1% | |
Gross profit margin | % | 17.2 | -37.9 | -45.4% | |
Effective tax rate | % | 10.4 | 9.6 | 108.8% | |
Net profit margin | % | 27.3 | 39.4 | 69.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 55 | 14,206.8% | |
Current liabilities | Rs m | 2,683 | 14 | 18,551.9% | |
Net working cap to sales | % | 136.7 | 137.0 | 99.8% | |
Current ratio | x | 2.9 | 3.8 | 76.6% | |
Inventory Days | Days | 1,201 | 32,466 | 3.7% | |
Debtors Days | Days | 35 | 118,190 | 0.0% | |
Net fixed assets | Rs m | 12,656 | 2,637 | 480.0% | |
Share capital | Rs m | 123 | 11 | 1,142.6% | |
"Free" reserves | Rs m | 7,634 | 2,442 | 312.6% | |
Net worth | Rs m | 7,757 | 2,452 | 316.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 2,692 | 762.1% | |
Interest coverage | x | 66.9 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0 | 1,666.6% | |
Return on assets | % | 5.1 | 0.4 | 1,175.2% | |
Return on equity | % | 13.3 | 0.5 | 2,784.4% | |
Return on capital | % | 15.1 | 0.5 | 2,853.2% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | -14 | -3,291.7% | |
From Investments | Rs m | -1,533 | 6 | -26,886.0% | |
From Financial Activity | Rs m | -305 | -4 | 7,055.6% | |
Net Cashflow | Rs m | -1,389 | -12 | 11,359.8% |
Indian Promoters | % | 0.0 | 70.3 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 0.1 | 788.9% | |
FIIs | % | 0.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 29.7 | 98.8% | |
Shareholders | 41,239 | 560 | 7,364.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA VINYL CHEMICALS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | KEMP & CO | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.95% | 0.11% | 0.35% |
1-Month | 4.80% | 3.14% | 2.33% |
1-Year | 76.71% | 38.07% | 54.34% |
3-Year CAGR | 20.99% | 33.70% | 15.02% |
5-Year CAGR | 8.52% | 8.85% | 19.24% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the KEMP & CO share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of KEMP & CO the stake stands at 70.3%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of KEMP & CO.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
KEMP & CO paid Rs 12.0, and its dividend payout ratio stood at 110.4%.
You may visit here to review the dividend history of Novartis, and the dividend history of KEMP & CO.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets Slipped further as the session progressed and ended the day weak.